Merit Medical Systems, Inc. recently announced the United States commercial release of the Prelude Wave hydrophilic sheath intro ...

BioLab Holdings, Inc., recently announced the initiation of the BIOCAMP study assessing the company’s human placental memb ...

Instylla, Inc. announced premarket approval (PMA) from the FDA for the company’s flagship Embrace hydrogel embolic system.

HistoSonics, the developer of the Edison histotripsy system and histotripsy therapy platform, announced a management-led majority ...

Royal Philips recently announced FDA 510(k) clearance of the latest version of the company’s UroNav system for image-guided ...

Instylla, Inc., a privately held clinical-stage company developing solutions for peripheral vascular embolization, announced ...

The Society of Interventional Oncology (SIO) recently announced the completion of enrollment for its clinical trial, ...

J uly 29, 2025—Inari Medical, now part of Stryker, announced the launch of its next-generation InThrill thrombectomy system. According to the company, InThrill is a purpose-built, small vessel and ...

July 29, 2025—Vexev and U.S. Renal Care announced the completion of enrollment in the CANSCAN clinical trial, a multicenter feasibility study evaluating the use of semiautonomous ultrasound scanning ...